ISU ABXIS to Present at Neuroscience 2021

ISU ABXIS (KOSDAQ: 086890) announced the presentation of research data on the discovery of first-in-class antibody therapeutics for Alzheimer disease at Neuroscience 2021, the 50th Annual Meeting of the Society for Neuroscience.

Neuroscience 2021 is one of the world's largest neuroscience conferences attending 30,000 experts, scholars in the field of neuroscience and participating 500 global companies such as Novartis and Sanofi from 80 countries every year. This event will be held from 8 to 11 November 2021 virtually, and from 13 to 16 November 2021 at McCormick Place Convention Center, in Chicago, Illinois.